Cell-surface co-receptors: emerging roles in signaling and human disease

被引:60
作者
Kirkbride, KC
Ray, BN
Blobe, GC [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA
关键词
D O I
10.1016/j.tibs.2005.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular signals are transmitted to cells through two classes of cell-surface receptors: signaling receptors that directly transduce signals and signaling co-receptors that bind ligand but that, traditionally, have not been thought to signal directly. Signaling co-receptors modulate the ligand binding and signaling of their respective signaling receptors. In recent years, roles for co-receptors have expanded to include essential functions in morphogen gradient formation, localizing signaling, signaling independently, regulating cell adhesion and orchestrating the signaling of several pathways. The importance of signaling co-receptors is demonstrated by their ubiquitous expression, their conservation during evolution, their prominent role in signaling cascades, their indispensable role during development and their frequent mutation or altered expression in human disease.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 105 条
[91]   Syndecans - New kids on the signaling block [J].
Tkachenko, E ;
Rhodes, JM ;
Simons, M .
CIRCULATION RESEARCH, 2005, 96 (05) :488-500
[92]   Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q [J].
Toomes, C ;
Bottomley, HM ;
Jackson, RM ;
Towns, KV ;
Scott, S ;
Mackey, DA ;
Craig, JE ;
Jiang, L ;
Yang, ZL ;
Trembath, R ;
Woodruff, G ;
Gregory-Evans, CY ;
Gregory-Evans, K ;
Parker, MJ ;
Black, GCM ;
Downey, LM ;
Zhang, K ;
Inglehearn, CF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (04) :721-730
[93]  
Van Uden E, 2000, MICROSC RES TECHNIQ, V50, P268, DOI 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO
[94]  
2-1
[95]   Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density [J].
Van Wesenbeeck, L ;
Cleiren, E ;
Gram, J ;
Beals, RK ;
Bénichou, O ;
Scopelliti, D ;
Key, L ;
Renton, T ;
Bartels, C ;
Gong, YQ ;
Warman, ML ;
de Vernejoul, MC ;
Bollerslev, J ;
Van Hul, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :763-771
[96]   A model for GFRα4 function and a potential modifying role in multiple endocrine neoplasia 2 [J].
Vanhorne, JB ;
Andrew, SD ;
Harrison, KJ ;
Taylor, SAM ;
Thomas, B ;
McDonald, TJ ;
Ainsworth, PJ ;
Mulligan, LM .
ONCOGENE, 2005, 24 (06) :1091-1097
[97]   The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1 [J].
Velasco-Loyden, G ;
Arribas, J ;
López-Casillas, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) :7721-7733
[98]   Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system [J].
von Schack, D ;
Casademunt, E ;
Schweigreiter, R ;
Meyer, M ;
Bibel, M ;
Dechant, G .
NATURE NEUROSCIENCE, 2001, 4 (10) :977-978
[99]   Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma [J].
Wechselberger, C ;
Strizzi, L ;
Kenney, N ;
Hirota, M ;
Sun, YP ;
Ebert, A ;
Orozco, O ;
Bianco, C ;
Khan, NI ;
Wallace-Jones, B ;
Normanno, N ;
Adkins, H ;
Sanicola, M ;
Salomon, DS .
ONCOGENE, 2005, 24 (25) :4094-4105
[100]   Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2 [J].
West, DC ;
Rees, CG ;
Duchesne, L ;
Patey, SJ ;
Terry, CJ ;
Turnbull, JE ;
Delehedde, M ;
Heegaard, CW ;
Allain, F ;
Vanpouille, C ;
Ron, D ;
Fernig, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :13457-13464